Selegiline Rx

Select the drug indication to add to your list

Selegiline

Parkinsonism
Only 4 drugs may be compared at once

Generic Name and Formulations:

Selegiline HCl 5mg; caps.

Select therapeutic use:

Indications for Selegiline:

Adjunct to levodopa/carbidopa in Parkinsonism.

Adult:

5mg at breakfast and at lunch; max 10mg/day. After 2–3 days, levodopa/carbidopa dosage may be reduced by 10–30%; further reductions may be possible later.

Children:

Not established.

Contraindications:

Concomitant meperidine, possibly other opioids.

Warnings/Precautions:

Selectivity for MAO type B diminishes at doses over 10mg/day. Pregnancy (Cat.C). Nursing mothers: not recommended.

Pharmacological Class:

MAO-B inhibitor.

Interactions:

See Contraindications. Avoid concomitant tricyclic antidepressants or selective serotonin reuptake inhibitors (SSRIs). Allow at least 5 weeks (or more if used chronically or at high doses) between fluoxetine discontinuance and 2 weeks between paroxetine or sertraline discontinuance before starting selegiline; allow 2 weeks between selegiline discontinuance before starting tricyclic antidepressants or SSRIs. Caution with tyramine-containing foods and with sympathomimetics.

Adverse Reactions:

Nausea, dizziness, lightheadedness, syncope, abdominal pain, confusion, vivid dreams, hallucinations, dry mouth, headache.

Note:

Formerly known under the brand name Eldepryl.

How Supplied:

Contact supplier